Literature DB >> 31402317

Non-covalent NRF2 Activation Confers Greater Cellular Protection than Covalent Activation.

Pengfei Liu1, Wang Tian1, Shasha Tao1, Joseph Tillotson1, E M Kithsiri Wijeratne2, A A Leslie Gunatilaka2, Donna D Zhang3, Eli Chapman4.   

Abstract

The transcription factor NRF2 confers cellular protection by maintaining cellular redox homeostasis and proteostasis. Basal NRF2 levels are normally low due to KEAP1-mediated ubiquitylation and subsequent proteasomal degradation. KEAP1, a substrate adaptor protein of a KEAP1-CUL3-RBX1 E3 ubiquitin ligase complex, contains a critical cysteine (C151) that is modified by electrophiles or oxidants, resulting in inactivation of the E3 ligase and inhibition of NRF2 degradation. Currently, nearly all NRF2 inducers are electrophilic molecules that possess unwanted off-target effects due to their reactive nature. Here, we report a group of NRF2 inducers, ent-kaurane diterpenoid geopyxins, with and without C151 reactive electrophilic moieties. Among 16 geopyxins, geopyxin F, a non-electrophilic NRF2 activator, showed enhanced cellular protection relative to an electrophilic NRF2 activator, geopyxin C. To our knowledge, this is the first detailed structure-activity relationship study of covalent versus non-covalent NRF2 activators, showing the promise of non-covalent NRF2 activators as potential therapeutic compounds.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NRF2; cancer; chemoprevention; drug discovery; geopyxin; natural product; non-covalent; structure activity relationship

Mesh:

Substances:

Year:  2019        PMID: 31402317      PMCID: PMC6800637          DOI: 10.1016/j.chembiol.2019.07.011

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  51 in total

1.  Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.

Authors:  Donna D Zhang; Mark Hannink
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

2.  Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.

Authors:  Donna D Zhang; Shih-Ching Lo; Janet V Cross; Dennis J Templeton; Mark Hannink
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

3.  p97 Negatively Regulates NRF2 by Extracting Ubiquitylated NRF2 from the KEAP1-CUL3 E3 Complex.

Authors:  Shasha Tao; Pengfei Liu; Gang Luo; Montserrat Rojo de la Vega; Heping Chen; Tongde Wu; Joseph Tillotson; Eli Chapman; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2017-03-31       Impact factor: 4.272

4.  Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis.

Authors:  Zheng-Yu Jiang; Meng-Chen Lu; Li Li Xu; Ting-Ting Yang; Mei-Yang Xi; Xiao-Li Xu; Xiao-Ke Guo; Xiao-Jin Zhang; Qi-Dong You; Hao-Peng Sun
Journal:  J Med Chem       Date:  2014-02-21       Impact factor: 7.446

5.  Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates.

Authors:  Y Zhang; T W Kensler; C G Cho; G H Posner; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.

Authors:  Akira Kobayashi; Moon-Il Kang; Hiromi Okawa; Makiko Ohtsuji; Yukari Zenke; Tomoki Chiba; Kazuhiko Igarashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

7.  Systemic administration of the apocarotenoid bixin protects skin against solar UV-induced damage through activation of NRF2.

Authors:  Shasha Tao; Sophia L Park; Montserrat Rojo de la Vega; Donna D Zhang; Georg T Wondrak
Journal:  Free Radic Biol Med       Date:  2015-11-04       Impact factor: 7.376

Review 8.  Update on potential drugs for the treatment of diabetic kidney disease.

Authors:  Brian Shepler; Christy Nash; Cory Smith; Abbey Dimarco; Josie Petty; Stephanie Szewciw
Journal:  Clin Ther       Date:  2012-05-11       Impact factor: 3.393

9.  Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis.

Authors:  Tongde Wu; Fei Zhao; Beixue Gao; Can Tan; Naoko Yagishita; Toshihiro Nakajima; Pak K Wong; Eli Chapman; Deyu Fang; Donna D Zhang
Journal:  Genes Dev       Date:  2014-03-17       Impact factor: 11.361

Review 10.  The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders.

Authors:  Bifeng Gao; An Doan; Brooks M Hybertson
Journal:  Clin Pharmacol       Date:  2014-02-03
View more
  9 in total

1.  The role of natural products in revealing NRF2 function.

Authors:  Donna D Zhang; Eli Chapman
Journal:  Nat Prod Rep       Date:  2020-05-13       Impact factor: 13.423

Review 2.  The intricacies of NRF2 regulation in cancer.

Authors:  Cody J Schmidlin; Aryatara Shakya; Matthew Dodson; Eli Chapman; Donna D Zhang
Journal:  Semin Cancer Biol       Date:  2021-05-18       Impact factor: 15.707

Review 3.  The roles of inducible chromatin and transcriptional memory in cellular defense system responses to redox-active pollutants.

Authors:  Caren Weinhouse
Journal:  Free Radic Biol Med       Date:  2021-03-28       Impact factor: 8.101

4.  COPD lung studies of Nrf2 expression and the effects of Nrf2 activators.

Authors:  Jian Li; James Baker; Andrew Higham; Rajesh Shah; Angeles Montero-Fernandez; Clare Murray; Nicky Cooper; Cathy Lucas; Craig Fox; Dave Singh; Simon Lea
Journal:  Inflammopharmacology       Date:  2022-04-20       Impact factor: 5.093

5.  Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas.

Authors:  Xianquan Zhan; Jiajia Li; Tian Zhou
Journal:  Front Pharmacol       Date:  2021-03-24       Impact factor: 5.810

Review 6.  Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment.

Authors:  Liaisan Arslanbaeva; Marco Bisaglia
Journal:  Molecules       Date:  2022-02-22       Impact factor: 4.411

Review 7.  Targeting NRF2 to treat cancer.

Authors:  Jared Sivinski; Donna D Zhang; Eli Chapman
Journal:  Semin Cancer Biol       Date:  2021-06-05       Impact factor: 15.707

8.  NRF2 regulates the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via FOCAD-FAK signaling pathway.

Authors:  Pengfei Liu; Di Wu; Jinyue Duan; Hexin Xiao; Yulai Zhou; Lei Zhao; Yetong Feng
Journal:  Redox Biol       Date:  2020-08-27       Impact factor: 11.799

9.  α-Lipoic Acid Targeting PDK1/NRF2 Axis Contributes to the Apoptosis Effect of Lung Cancer Cells.

Authors:  Liduo Yue; Yanbei Ren; Qingxi Yue; Zhou Ding; Kai Wang; Tiansheng Zheng; Guojie Chen; Xiangyun Chen; Ming Li; Lihong Fan
Journal:  Oxid Med Cell Longev       Date:  2021-06-04       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.